IFXY yields 666666.67% · PFE yields 6.13%● Live data
📍 IFXY pulled ahead of the other in Year 1
Combined, IFXY + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IFXY + PFE for your $10,000?
Infrax Systems, Inc. provides a series of interrelated operational management, communications, and electric power grid security related products and services that enable a unified solution for communications and applications management of the smart electric power grid. The company offers Secure Intelligent Energy Platform that offers utilities the ability to communicate with devices connected to the power grid. It also provides communication devices, including Secure Network Interface Card that resides in the utility power meter to encrypt and transport the data, such as usage, voltage, current, etc.; and collectors, concentrators, and repeaters. In addition, it offers GridMesh software that allows its hardware devices to securely join the network and communicate with each other; Utility Max (UMAX) and UMAX+ wireless solutions for electric power utilities and telephone carriers to set up a point-to-point or point-to-multipoint Ethernet links; and Grid Intrusion Management systems. Further, the company provides distribution automation solution for two-way communications from distribution devices along the power grid to the back office or substations; managed services and customer support, such as network design, deployment support, and program management; and professional services comprising engineering, construction, and project management services to the smaller utilities. Additionally, it offers asset tracker solution for the inventory management of utility smart electric power grid assets, including meters, collectors, and concentrators, as well as substation and field deployable assets. The company was formerly known as OptiCon Systems, Inc. and changed its name to Infrax Systems, Inc. in January 2010. Infrax Systems, Inc. was founded in 2004 and is based in St. Petersburg, Florida.
Full IFXY Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.